相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Distinguishing immune activation and inflammatory signatures of multisystem inflammatory syndrome in children (MIS-C) versus hemophagocytic lymphohistiocytosis (HLH)
Deepak Kumar et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)
T-cell activation profiles distinguish hemophagocytic lymphohistiocytosis and early sepsis
Vandana Chaturvedi et al.
BLOOD (2021)
Monocytes From Patients With Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis Are Hyperresponsive to Interferon Gamma
Antonia Pascarella et al.
FRONTIERS IN IMMUNOLOGY (2021)
Polyclonal expansion of TCR Vβ 21.3+ CD4+ and CD8+ T cells is a hallmark of multisystem inflammatory syndrome in children
Marion Moreews et al.
SCIENCE IMMUNOLOGY (2021)
Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis
Pui Y. Lee et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
On the Alert for Cytokine Storm: Immunopathology in COVID-19
Lauren A. Henderson et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis
F. Locatelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
COVID-19 Severity Correlates with Weaker T-Cell Immunity, Hypercytokinemia, and Lung Epithelium Injury
Zhongfang Wang et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses
Runhong Zhou et al.
IMMUNITY (2020)
Successful treatment of secondary macrophage activation syndrome with emapalumab in a patient with newly diagnosed adult-onset Still's disease: case report and review of the literature
Jihad Ben Gabr et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
Divij Mathew et al.
SCIENCE (2020)
Immunological and inflammatory profiles in mild and severe cases of COVID-19
Jin-Wen Song et al.
NATURE COMMUNICATIONS (2020)
Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension
Qiang Zeng et al.
FRONTIERS IN IMMUNOLOGY (2020)
EMAPALUMAB (ANTI-INTERFERON-GAMMA MONOCLONAL ANTIBODY) IN PATIENTS WITH MACROPHAGE ACTIVATION SYNDROME (MAS) COMPLICATING SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA)
F. De Benedetti et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Hemophagocytic Lymphohistiocytosis in a Patient With Multiple Myeloma
Caroline M. Hsu et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2019)
Interleukin-18 in pediatric rheumatic diseases
Giusi Prencipe et al.
CURRENT OPINION IN RHEUMATOLOGY (2019)
Emapalumab for the treatment of relapsed/refractory hemophagocytic lymphohistiocytosis
Mounica Vallurupalli et al.
BLOOD (2019)
A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function
Michael T. Lam et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
The Immunology of Macrophage Activation Syndrome
Courtney B. Crayne et al.
FRONTIERS IN IMMUNOLOGY (2019)
Treatment of refractory hemophagocytic lymphohistiocytosis with emapalumab despite severe concurrent infections
Dana T. Lounder et al.
BLOOD ADVANCES (2019)
Lymphocyte-independent pathways underlie the pathogenesis of murine cytomegalovirus-associated secondary haemophagocytic lymphohistiocytosis
E. Brisse et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2018)
Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
Claudia Bracaglia et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Peripheral human CD4+CD8+ T lymphocytes exhibit a memory phenotype and enhanced responses to IL-2, IL-7 and IL-15
Marie-Laure Clenet et al.
SCIENTIFIC REPORTS (2017)
Advances in the pathogenesis of primary and secondary haemophagocytic lymphohistiocytosis: differences and similarities
Ellen Brisse et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Macrophage activation syndrome in the era of biologic therapy
Alexei A. Grom et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative
Angelo Ravelli et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-gamma
Karen Put et al.
RHEUMATOLOGY (2015)
An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome
Scott W. Canna et al.
NATURE GENETICS (2014)
Neutralization of IFNγ defeats haemophagocytosis in LCMV-infected perforin- and Rab27a-deficient mice
Jana Pachlopnik Schmid et al.
EMBO MOLECULAR MEDICINE (2009)
A Griscelli syndrome type 2 murine model of hemophagocytic lymphohistiocytosis (HLH)
Jana Pachlopnik Schmid et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
Jan-Inge Henter et al.
PEDIATRIC BLOOD & CANCER (2007)
CD4 expression on activated NK cells: Ligation of CD4 induces cytokine expression and cell migration
Helene B. Bernstein et al.
JOURNAL OF IMMUNOLOGY (2006)
The CD4 molecule on CD8+ T lymphocytes directly enhances the immune response to viral, and cellular antigens
SG Kitchen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Macrophage activation syndrome:: characteristic findings on liver biopsy illustrating the key role of activated, IFN-γ-producing lymphocytes and IL-6- and TNF-α-producing macrophages
AD Billiau et al.
BLOOD (2005)
An animal model of hemophagocytic lymphohistiocytosis (HLH):: CD8+ T cells and interferon gamma are essential for the disorder
MB Jordan et al.
BLOOD (2004)
CD4 on CD8+ T cells directly enhances effector function and is a target for HIV infection
SG Kitchen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Upregulation of CD4 on CD8+ T cells:: CD4dimCD8bright T cells constitute an activated phenotype of CD8+ T cells
YB Sullivan et al.
IMMUNOLOGY (2001)
分享论文
